HOME / INVESTOR RELATIONS / GET NOTIFIED

Get notified

Name*

Surname*

E-mail*

Company*

Privacy policy pursuant to Article 13 of EU Regulation 2016/679

Pursuant to Article 13 of EU Regulation 2016/679 (known as "GDPR"), we would like to inform You that Your personal data (name, last name, and email address) shall be processed by NEOPHARMED GENTILI S.p.A. in its capacity of Data Controller, mainly by electronic means, with the sole purpose of granting you access to the section of the website dedicated to professional investors. Your data shall be processed only for the amount of time necessary to: i) grant you access to that specific area of the website; ii) send you communications relating to your role as a professional investor. Your data shall be erased following 12 months of inactivity on Your part or following an express request from You.

The Legal Basis of the processing referred to in point i) is the performance of pre-contractual/contractual activities requested by the Data Subject (Article 6(1)(b) of GDPR). The Legal Basis of the processing referred to in point ii) is the pursuit of the legitimate interests of the Data Controller (Article 6(1)(f) of the GDPR). The submission of your personal data is entirely voluntary; however, failure to provide the requested data will prevent us from giving you access to the investor section of the website. We would also like to inform you that, should You decide to submit your personal data, they shall be processed by personnel authorized to do so by the Data Controller. Your data shall not be disseminated under any circumstances.

Furthermore, we would like to remind You that, in accordance with Articles 15 to 21 of the General Data Protection Regulation, You have the right to obtain confirmation as to whether or not personal data concerning You exist; to know the source of the data, as well as to confirm the purposes for which they are processed and the processing methods. Additionally, You have the right of data portability, update, rectification, restriction, and erasure, barring the need for them to be retained for the purpose of fulfilling any legal obligations.

To exercise these rights, you may contact the Data Controller by sending an email to the following address: info@neogen.it or by sending an email to the appointed Data Protection Officer at the following address: dpo@neogen.it. You also have the right to lodge a complaint with a supervisory authority if You believe that the rights referred to herein have not been afforded to you.

I agree to receive emails

I have read and agree to the investor privacy policy

IMPORTANT NOTICE: You must read the following information before continuing.
Access to the information and documents on the portion of our website that follows this disclaimer (the “IR Section”) is restricted for regulatory reasons. By accessing the IR Section you will be deemed to have read and accepted the terms of this disclaimer. The information contained in the IR Section and in the reports, financial statements, press releases, presentations and other documents available in the IR Section (the “Information”) does not constitute an offer to sell or a solicitation of an offer to buy any securities of Neopharmed S.p.A. (the “Company”) or any of its subsidiaries or affiliates. You must comply with all laws that apply to you in any place in which you buy, offer or sell any securities or access or possess the Information.
Any securities referred to in the Information have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and may be offered or sold only to investors who are either (i) qualified institutional buyers (within the meaning of Rule 144A under the Securities Act) in the United States or (ii) outside the United States in offshore transactions in accordance with Regulation S under the Securities Act (and, if investors are resident in a member state of the European Economic Area, a qualified investor, within the meaning of Article 2(e) of Regulation (EU) 2017/1129, as amended, and any relevant implementing measure in each member state of the European Economic Area).
You acknowledge that the information and statements contained in the document you are accessing on this website speak only as of the date of such document (or such other date(s) specified therein), and such information and statements may become inaccurate, stale and/or out-of-date thereafter and should not be relied upon for any investment decision. You acknowledge that the materials on this website that you are accessing are confidential and intended only for you and you agree you will not forward, reproduce, copy, download or publish any of such materials (electronically or otherwise) to any other person if this is not in accordance with the law.
You acknowledge that the access to information and documents contained on this portion of the website may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access this portion of the website. If you are not authorized to access the information and document contained on this portion of the website or you are not sure that you are permitted to view these materials, you should leave this portion of the website.
You acknowledge that no registration or approval has been obtained and the Company and its affiliates assume no responsibility if there is a violation of applicable law and regulation by any person. By clicking the button below labeled “Yes”, you are confirming that you have read and understood the disclaimer above. If you cannot so confirm, you must click the button labelled “No” or otherwise exit this portion of the website.

I have read and confirm the disclaimer*

* required fields

Get notified

Disclaimer